Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Visigalli

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|August 4, 2022
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBSMargherita Bellucci, Francesco Germano, Stefano Grisanti, et al.
Scientific Reports|August 12, 2017
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathiesGiovanna Capodivento, Davide Visigalli, Martina Garnero, et al.
Frontiers in Neurology|September 28, 2020
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1ADavide Visigalli, Giovanna Capodivento, Abdul Basit, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2020
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBSGiovanna Capodivento, Chiara De Michelis, Marinella Carpo, et al.
Biomarker Insights|July 8, 2025
A Comprehensive Description of the Roadmap to Identify and Validate a Myelin BiomarkerGiovanna Capodivento, Davide Visigalli, Andrea Armirotti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2024
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndromeFederico Massa, Tiziana Vigo, Margherita Bellucci, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Frontiers in Immunology|August 4, 2022
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBSMargherita Bellucci, Francesco Germano, Stefano Grisanti, et al.
Scientific Reports|August 12, 2017
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathiesGiovanna Capodivento, Davide Visigalli, Martina Garnero, et al.
Frontiers in Neurology|September 28, 2020
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1ADavide Visigalli, Giovanna Capodivento, Abdul Basit, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2020
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBSGiovanna Capodivento, Chiara De Michelis, Marinella Carpo, et al.
Biomarker Insights|July 8, 2025
A Comprehensive Description of the Roadmap to Identify and Validate a Myelin BiomarkerGiovanna Capodivento, Davide Visigalli, Andrea Armirotti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2024
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndromeFederico Massa, Tiziana Vigo, Margherita Bellucci, et al.
Pageof 2